Modulation of Warfarin Sodium into Warfarin Potassium for Patients with Hypertension

Authors

  • Al-Baraa Akram

warfain, hypertension, international normalized ratio, therapeutic window, clinical trials, pharmaco-genomics, CYP2C9*3

Abstract

Abstract not found

How to Cite

Modulation of Warfarin Sodium into Warfarin Potassium for Patients with Hypertension. (2022). Global Journal of Science Frontier Research, 22(26), 1-14. https://www.journalofscience.org/index.php/GJSFR/article/view/102558

References

E. Ravina (2011) The Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs. 148.

The American Society of Health-System Pharmacists (2017) The American Society of Health-System Pharmacists. 2.

G. Lim (2017) Milestone 2: Warfarin: from rat poison to clinical use.

(2021) The Top 300 of 2019.

The American Society of Health-System Pharmacists (2011) The American Society of Health-System Pharmacists.

(2011) Warfarin diet: What foods should I avoid?.

J. Ansell, A. Jacobson, J. Levy, H. Völler, J. Hasenkam (2005) Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation" (PDF). 99(1), 37-45.

J. Levy, W. Ageno, N. Chan, M. Crowther, P. Verhamme, J. Weitz (2016) When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. 14(3), 623-627.

O. Macina, J. Schardein (2007) Warfarin". Human Developmental Toxicants. 193-194.

A. Holbrook, S. Schulman, D. Witt, P. Vandvik, J. Fish, M. Kovacs (2012) Evidencebased management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 152S-e184.

D. Garcia, M. Crowther, W. Ageno (2010) Practical management of coagulopathy associated with warfarin. 340(apr19 1), c1813-c1813. https://doi.org/10.1136/bmj.c1813

Deanna Brown, Eric Wilkerson, W. Love (2015) A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons. 72(3), 524-534. https://doi.org/10.1016/j.jaad.2014.10.027

A. Camm, G. Lip, De Caterina, R. Savelieva, I. Atar, D. Hohnloser, S. (2012) (November 2012) "2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association". 33(21), 2719-2747.

M. Shoeb, M. Fang (2013) Assessing bleeding risk in patients taking anticoagulants. 35(3), 312-319.

Meghan Elliott, Deborah Zimmerman, Rachel Holden (2007) Warfarin Anticoagulation in Hemodialysis Patients: A Systematic Review of Bleeding Rates. 50(3), 433-440. https://doi.org/10.1053/j.ajkd.2007.06.017

M. Fang, A. Go, Y. Chang, L. Borowsky, N. Pomernacki, N. Udaltsova, D. Singer (2011) A new risk scheme to predict warfarinassociated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. 58(4), 395-401.

Zhu Y, Shennan M, Reynolds KK, Johnson NA, Herrnberger MR, Valdes Jr (2007) Estimation of warfarin maintenance dose based on VKORC1 (−1639 G>A) and CYP2C9 genotypes.

Caldwell MD, Berg RL, Zhang KQ, Glurich I, Schmelzer JR, Yale SH Evaluation of genetic factors for warfarin dose prediction.

C. Kealey, Z. Chen, J. Christie, C. Thorn, A. Whitehead, M. Price Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity.

Modulation of Warfarin Sodium into Warfarin Potassium for Patients with Hypertension

Published

2022-09-05

How to Cite

Modulation of Warfarin Sodium into Warfarin Potassium for Patients with Hypertension. (2022). Global Journal of Science Frontier Research, 22(26), 1-14. https://www.journalofscience.org/index.php/GJSFR/article/view/102558